Skip to main content
. 2021 Aug 6;12:609213. doi: 10.3389/fphar.2021.609213

TABLE 4.

Summary of findings.

TCM plus routine treatment compared to standard treatment for COVID-19
Patient or population: COVID-19
Setting: RCT
Intervention: TCM plus routine treatment
Comparison: Routine treatment
Outcome
№ of participants (studies)
Relative effect (95% CI) Anticipated absolute effects (95% CI) Certainty
Risk without TCM treatment Risk with TCM treatmenta Risk Difference
Clinical cure
№ of participants: 357 (2 RCTs)
RR 1.20 (1.04 to 1.38) 59.0% 70.8% (61.3 to 81.4) 11.8% more (2.4 more to 22.4 more) ⊕⊕⊕○
MODERATEb
The negativity of SARS-CoV-2 nucleic acid test
№ of participants: 324 (2 RCTs)
RR 1.08 (0.94 to 1.23) 67.9% 73.3% (63.8 to 83.5) 5.4% more (4.1 fewer to 15.6 more) ⊕○○○
VERY LOWb , c , d
Clinical deterioration
№ of participants: 414 (3 RCTs)
RR 0.39 (0.18 to 0.86) 9.7% 3.8% (1.7 to 8.3) 5.9% fewer (8 fewer to 1.4 fewer) ⊕⊕⊕○
MODERATEb
ARDS
№ of participants: 104 (2 RCTs)
RR 0.28 (0.11 to 0.69) 35.3% 9.9% (3.9 to 24.4) 25.4% fewer (31.4 fewer to 10.9 fewer) ⊕⊕⊕○
MODERATEb
Mechanical ventilation
№ of participants: 146 (3 RCTs)
RR 0.30 (0.12 to 0.77) 26.2% 7.8% (3.1 to 20.1) 18.3% fewer (23 fewer to 6 fewer) ⊕⊕⊕○
MODERATEb
Chest image improvement
№ of participants: 627 (3 RCTs)
RR 1.22 (1.07 to 1.39) 63.7% 77.7% (68.2 to 88.5) 14.0% more (4.5 more to 24.8 more) ⊕⊕⊕○
MODERATEd
Death
№ of participants: 482 (3 RCTs)
RR 0.28 (0.09 to 0.84) 6.2% 1.7% (0.6 to 5.2) 4.5% fewer (5.7 fewer to 1 fewer) ⊕⊕⊕○
MODERATEb
a

The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio

Explanations:

b

Small sample size, the optimal information size criterion is not met.

c

95% CI overlaps no effect (RR of 1.0).

d

The clinical heterogeneity between the trials exists, so we rate down for this outcome.

The bold was provided by GRADE to highlight the effect